William Blair Assigned “an Outperform” Rating to Aileron Therapeutics Inc (NASDAQ:ALRN) Stock
William Blair raised the price target for the Aileron Therapeutics Inc (NASDAQ:ALRN) stock to “an Outperform”. The rating was released on July 24, 2017, according to finviz. The research report from BofA/Merrill has initiated the stock to Buy, with a price target set at $19. The latest trade, Performances and Moving Averages give us the […]